Pharma channel feed – Endpoints News

Pharma channel feed

Implementing 'Right-to-Try': FDA signals likelihood of only minimal manufacturer participation

3 years ago

Moonshot refresh: Biden calls to cut cancer death rate by at least 50% in 25 years

3 years ago

FDA schedules joint advisory committee meeting to consider first over-the-counter birth control pill

3 years ago

Adagio adopts new name, adds Covid cocktail candidate in ‘new day’ bid after initial drug development woes

3 years ago

Verily hooks $1B round amid C-suite shuffle

3 years ago

In the middle of an R&D shakeup, Novartis makes a $300M investment in early-stage biologics research tech

3 years ago

#ESMO22: 'End of the beginning': As PD-(L)1s press on, how far can combo therapies take immuno-oncology?

3 years ago

Manufacturers sound off on FDA drug reporting guidance, pointing to challenges and recommendations

3 years ago

Colorado to seek FDA approval by fall on Canadian drug imports

3 years ago

Merck Foundation debuts $20M health equity fund focused on cancer care

3 years ago

J&J settles gender discrimination and retaliation allegations involving former CEO and R&D head

3 years ago

Pharma companies need to speak the right language to reach growing Hispanic patient populations

3 years ago

Brand name inhalers are very good at blocking competition, better even than nebulizers, study finds

3 years ago

#ESMO22: At five-year mark, Lynparza kept more patients alive than Avastin but missed overall OS significance

3 years ago

Teva fires back at GSK again over potential 'skinny' label SCOTUS case

3 years ago

Pharma and healthcare digital ad spending slows after pandemic increase, but still headed for $20B — report

3 years ago

Merck KGaA continues expansion with $285M+ investment in 2 new projects in France and Germany

3 years ago

'Discriminatory and dangerous': Pharma companies and advocates slam Texas judge's HIV coverage decision

3 years ago

Blockbuster franchise expands: Regeneron shares spike on new high-dose Eylea data

3 years ago

Australian CRO makes a move across the Pacific for US acquisition

3 years ago

Longer-lasting Botox competitor nabs FDA approval — can it compete with AbbVie's $2B cash cow?

3 years ago

Adcomm votes 7-2 in favor of Amylyx's ALS drug on second take. But first the co-CEOs had to make a pledge

3 years ago

New study reveals the extent to which drugmakers use condition-specific charities to induce spending on costly drugs

3 years ago

Genentech, Novartis re-up chronic hive campaign with celebrity comedian spokesperson

3 years ago

First page Previous page 174 175 176177178 179 180 Next page Last page